Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
ACARIZAX Standardised allergen extract from American house dust mite extract European house dust mite extract 12 SQ-HDM sublingual tablet, Seqirus Pty Ltd, CON-904
Product name
ACARIZAX Standardised allergen extract from American house dust mite extract European house dust mite extract 12 SQ-HDM sublingual tablet
Sponsor name
Seqirus Pty Ltd
Consent start
Consent no.
CON-904
Standard
Subparagraphs 10(14)(a)(v) and 10(14)(a)(ix) of Therapeutic Goods Order No. 91 '“ Standard for labels of prescription and related medicines (TGO91)
Non-compliance with standard
The product does not conform to the requirements of subparagraphs 10(14)(a)(v)
and 10(14)(a)(ix) of Therapeutic Goods Order No. 91 '“ Standard for labels of
prescription and related medicines (TGO91), in that The name of the active
ingredient (American house dust mite extract amp; European house dust mite
extract) is not included.The name of the sponsor is not included.
Conditions imposed
The ACARIZAX label exempted from TGO 91 requirements is identical to that
approved by the Therapeutic Goods Administration and presented with the
submission.
Therapeutic product type
Prescription medicines